LEILUNA LLC – Trademark Portfolio
Entity Type: 16
LEILUNA LLC owns a portfolio of 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as OPTML, CURAEO, NOVAEO, AYADARA, and TEAKI HUT. Of these, 14 are registered. The portfolio spans 5 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 3 (Cosmetics & Cleaning). Headquartered in WILMINGTON, DE.
4023 KENNETT PIKE #58301
WILMINGTON, DE 19807
Showing of trademarks Trademarks
Trademark Classifications
LEILUNA LLC's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does LEILUNA LLC have?
LEILUNA LLC has 21 U.S. trademarks filed with the USPTO. Of these, 14 registered, 7 abandoned.
What trademark classes does LEILUNA LLC file in?
LEILUNA LLC files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 30 (Staple Foods), Class 35 (Advertising & Business), Class 25 (Clothing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are LEILUNA LLC's most well-known trademarks?
LEILUNA LLC's registered trademark portfolio includes well-known marks such as OPTML, CURAEO, NOVAEO, AYADARA, and TEAKI HUT. These are among 14 currently registered trademarks in the portfolio.
What is LEILUNA LLC's trademark registration success rate?
LEILUNA LLC has a 67% trademark registration rate, with 14 out of 21 resolved applications resulting in successful registration. Currently, 0 applications are pending review.